Clinical trial
Omega 3 Fatty Acids in the Treatment of Children With Autism Spectrum Disorders
NCT00467818 · University of Medicine and Dentistry of New Jersey, Other · Completed
Key facts
| NCT number | NCT00467818 |
|---|---|
| Title | Omega 3 Fatty Acids in the Treatment of Children With Autism Spectrum Disorders |
| Official title | Omega 3 Fatty Acids in the Treatment of Children With Autism Spectrum Disorders |
| Lead sponsor | University of Medicine and Dentistry of New Jersey, Other |
| Collaborators | National Center for Complementary and Integrative Health (NCCIH) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Autism |
| Intervention type | Drug, Other |
| Interventions | Omega 3 fatty acids, Placebo |
| Enrollment | 17 |
| Start date | Jan 1, 2007 |
| Primary completion | Dec 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | May 1, 2007 |
| Last update posted | Jan 26, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: